The beriberi analogy to myocardial infarction.
暂无分享,去创建一个
[1] J. Gofman,et al. Blood Lipids and Human Atherosclerosis , 1950, Circulation.
[2] R. Peters. ADDRESSES AND ORIGINAL ARTICLESTHE BIOCHEMICAL LESION IN VITAMIN B1 DEFICIENCY: APPLICATION OF MODERN BIOCHEMICAL ANALYSIS IN ITS DIAGNOSIS☆ , 1936 .
[3] G. Friesinger,et al. PLATELET AGGREGATES IN PERIPHERAL AND CORONARY-SINUS BLOOD IN PATIENTS WITH SPONTANEOUS CORONARY-ARTERY SPASM , 1980, The Lancet.
[4] E. Benditt. The origin of atherosclerosis. , 1977, Scientific American.
[5] R. O’meara,et al. Cytological observations on carcinoma , 1958, Irish journal of medical science.
[6] S. Chierchia,et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. , 1978, The New England journal of medicine.
[7] Sinclair Hm. Deficiency of essential fatty acids and atherosclerosis, etcetera. , 1956 .
[8] J. McDonald,et al. Inhibition of human platelet cyclooxygenase by alpha-tocopherol. , 1980, Prostaglandins and medicine.
[9] I. Wright,et al. Report of the Committee for the Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction; a progress report on the statistical analysis of the first 800 cases studied by this committee. , 1948, American heart journal.
[10] M. Oliver. SERUM CHOLESTEROL-THE KNAVE OF HEARTS AND THE JOKER , 1981, The Lancet.
[11] P. B. Oliva,et al. Arteriographic Evidence of Coronary Arterial Spasm in Acute Myocardial Infarction , 1977, Circulation.
[12] J. Mcnee. The Clinical Syndrome of Thrombosis of the Coronary Arteries , 1925 .
[13] L. Mcdonald,et al. Changes in coagulability of the blood during various phases of ischaemic heart-disease. , 1959, Lancet.
[14] L. Michaels. CANCER INCIDENCE AND MORTALITY IN PATIENTS HAVING ANTICOAGULANT THERAPY. , 1964, Lancet.
[15] M. Ruckstuhl,et al. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. , 1979, Biochemical pharmacology.
[16] E. Wills,et al. MECHANISMS OF LIPID PEROXIDE FORMATION IN TISSUES. ROLE OF METALS AND HAEMATIN PROTEINS IN THE CATALYSIS OF THE OXIDATION UNSATURATED FATTY ACIDS. , 1965, Biochimica et biophysica acta.
[17] D F Horrobin,et al. A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2. , 1980, Medical hypotheses.
[18] P. Owren. CORONARY THROMBOSIS: ITS MECHANISM AND POSSIBLE PREVENTION BY LINOLENIC ACID. , 1965, Annals of internal medicine.
[19] L. Solberg,et al. Atherosclerosis in persons with coronary heart disease. , 1968, Laboratory investigation; a journal of technical methods and pathology.
[20] R. Chakrabarti,et al. Fibrinolytic activity related to age in survivors of myocardial infarction. , 1966, Lancet.
[21] E. Arnesen,et al. The Tromsø Heart Study , 1983 .
[22] M. Barrett,et al. Vitamin E inhibits arachidonic acid induced mortality and renal IgM deposition in rabbits. , 1980, Prostaglandins and medicine.
[23] K. Mccully,et al. Homocysteine theory of arteriosclerosis. , 1975, Atherosclerosis.
[24] J. Sullivan. IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK , 1981, The Lancet.
[25] T. Ariga,et al. PLATELET AGGREGATION INHIBITOR IN GARLIC , 1981, The Lancet.
[26] S. Dyke. THE BLOOD PLATELETS AND THEIR PLACE IN MEDICINE. , 1924 .
[27] A. Shaper,et al. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda. , 1959, Lancet.
[28] I. Gore,et al. Comparison of aortic atherosclerosis in the United States, Japan, and Guatemala. , 1959, The American journal of clinical nutrition.
[29] H. Griswold,et al. PROPHYLACTIC ANTICOAGULANT THERAPY FOR CORONARY ARTERY DISEASE. A SEVEN-YEAR CONTROLLED STUDY. , 1964, JAMA.
[30] A. Marcus. The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. , 1978, Journal of lipid research.
[31] G E Felton,et al. Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patients. , 1980, Medical hypotheses.
[32] R. O'Neal,et al. Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism. A geographic study based on autopsies in Uganda. East Africa and St. Louis, U.S.A. , 1960, The American journal of cardiology.
[33] A. Makheja,et al. INHIBITION OF PLATELET AGGREGATION AND THROMBOXANE SYNTHESIS BY ONION AND GARLIC , 1979, The Lancet.
[34] H. Wright,et al. Changes in the adhesiveness of blood platelets following parturition and surgical operations , 1942 .
[35] T. Anderson. Nutritional muscular dystrophy and human myocardial infarction. , 1973, Lancet.
[36] J. Mann,et al. Prudent diet: effect on moderately severe hyperlipidaemia. , 1982, British medical journal.
[37] R. O’meara. Coagulative properties of cancers , 1958, Irish Journal of Medical Science.
[38] J. Folkman,et al. Protamine is an inhibitor of angiogenesis , 1982, Nature.
[39] A. Willis,et al. Antithrombotic potential of dihomo-gamma-linolenic acid in man. , 1977, British medical journal.
[40] V. Kakkar,et al. Pyridoxal 5'-phosphate--a new physiological inhibitor of blood coagulation and platelet function. , 1979, Biochemical pharmacology.
[41] S. Moore. Platelet aggregation secondary to coronary obstruction. , 1976, Circulation.
[42] H. E. Burke,et al. BLOOD COAGULATION AS STUDIED BY INTRAVENOUS INJECTION OF TISSUE EXTRACT , 1926 .
[43] Rudin Do. The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra. , 1981 .
[44] D. Thelle,et al. THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.
[45] J. Vane,et al. HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION , 1977, The Lancet.